Vanguard Personalized Indexing Management, LLC Halozyme Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.09 Billion
- Q3 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 20,875 shares of HALO stock, worth $1.22 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,875
Previous 20,711
0.79%
Holding current value
$1.22 Million
Previous $1.08 Million
10.15%
% of portfolio
0.02%
Previous 0.02%
Shares
10 transactions
Others Institutions Holding HALO
# of Institutions
531Shares Held
122MCall Options Held
199KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$1.03 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$756 Million0.01% of portfolio
-
State Street Corp Boston, MA6.63MShares$389 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$238 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$200 Million0.07% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $8.16B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...